Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Molecular Insight Pharmaceuticals Inc.

Division of Progenics Pharmaceuticals Inc.
www.molecularinsight.com

Latest From Molecular Insight Pharmaceuticals Inc.

Gottlieb's Confirmation: Will Industry Ties Remain A Problem After The Hearing?

The US FDA commissioner does not generally get involved with day-to-day activities, former FDA chiefs say, but perception of bias could be a lasting problem.

FDA Regulation

Gottlieb's Confirmation: Will Industry Ties Remain A Big Deal After The Hearing?

The US FDA commissioner does not generally get involved with day-to-day activities, former FDA chiefs say, but perception of bias could be lasting problem.

FDA Leadership

US Capitol Capsule: Rare disease research hopeful, but therapy success remains low

It used to be that the FDA's regulatory focus on therapies to treat rare diseases involved only a small segment of the agency's activities.

Metabolic Disorders Cardiovascular

Deals Shaping The Medical Industry, February 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment –In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type –Acquisition, Alliance, or Financing.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Biostream Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Progenics Pharmaceuticals Inc.
  • Senior Management
  • Nelson K Stacks, PhD, CEO
    John W Babich, PhD, Pres. & CSO
  • Contact Info
  • Molecular Insight Pharmaceuticals Inc.
    Phone: (617) 492-5554
    160 Second St.
    Cambridge, MA 02142
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register